These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 20228500)

  • 1. Melanotic craniopharyngioma, an unusual variant in a young female.
    Ghosal N; Dadlani R; Kiran S; Hegde AS
    Neurol India; 2010; 58(1):160-2. PubMed ID: 20228500
    [No Abstract]   [Full Text] [Related]  

  • 2. Melanotic craniopharyngioma: a report of two cases.
    Harris BT; Horoupian DS; Tse V; Herrick MK
    Acta Neuropathol; 1999 Oct; 98(4):433-6. PubMed ID: 10502051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological study on craniopharyngioma with sebaceous differentiation.
    Tsunoda S; Sakaki T; Tsutsumi A; Eguchi T; Takeshima T; Morimoto T; Hashimoto H; Kiriishi R; Nakamura M; Tsuzuki T
    Noshuyo Byori; 1993; 10(1):69-74. PubMed ID: 8220784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composite pituitary adenoma and craniopharyngioma?: an unusual sellar neoplasm with divergent differentiation.
    Yoshida A; Sen C; Asa SL; Rosenblum MK
    Am J Surg Pathol; 2008 Nov; 32(11):1736-41. PubMed ID: 18769335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of craniopharyngiomas.
    Kubo O; Tajika Y; Uchimuno H; Muragaki Y; Shimoda M; Hiyama H; Morishita K; Takakura K
    Noshuyo Byori; 1993; 10(2):131-4. PubMed ID: 7693229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiologic response to MEK inhibition in a patient with a WNT-activated craniopharyngioma.
    Patel K; Allen J; Zagzag D; Wisoff J; Radmanesh A; Gindin T; Nicolaides T
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28753. PubMed ID: 33073916
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormone receptor expression in craniopharyngiomas: a clinicopathological correlation.
    Hofmann BM; Hoelsken A; Fahlbusch R; Blümcke I; Buslei R
    Neurosurgery; 2010 Sep; 67(3):617-25; discussion 625. PubMed ID: 20647974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of proliferating cell nuclear antigen in craniopharyngioma and tumor recurrence].
    Pan J; Qi ST; Deng YJ; Ding YQ; Peng L; Li XQ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):363-5. PubMed ID: 12390748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Craniopharyngioma with high FDG uptake.
    Nagata T; Kinoshita T; Kinoshita F; Moroi J; Miyata H
    Clin Nucl Med; 2012 Jan; 37(1):77-9. PubMed ID: 22157034
    [No Abstract]   [Full Text] [Related]  

  • 10. Ectopic recurrence of craniopharyngioma.
    Kawaguchi T; Fujimura M; Shirane R; Shoji T; Watanabe M; Tominaga T
    J Clin Neurosci; 2005 Apr; 12(3):307-9. PubMed ID: 15851090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI.
    Choi SH; Kwon BJ; Na DG; Kim JH; Han MH; Chang KH
    Clin Radiol; 2007 May; 62(5):453-62. PubMed ID: 17398271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Craniopharyngioma in a mother and daughter.
    Green AL; Yeh JS; Dias PS
    Acta Neurochir (Wien); 2002 Apr; 144(4):403-4. PubMed ID: 12021891
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of craniopharyngioma with intratumoral hemorrhage].
    Ishii K; Isono M; Hori S; Kinba Y; Mori T
    No Shinkei Geka; 1999 Jan; 27(1):73-7. PubMed ID: 10024988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitive squamous cell craniopharyngioma: clinical and pathological comparison with the adamantinomatous type.
    Inoue HK; Nakamura M; Ono N; Kohga H; Kakegawa T; Naitou I; Tamada J; Handa I
    Noshuyo Byori; 1993; 10(1):27-31. PubMed ID: 8220780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rathke's cleft cysts within a growth hormone producing pituitary adenoma.
    Nishio S; Fujiwara S; Morioka T; Fukui M
    Br J Neurosurg; 1995; 9(1):51-5. PubMed ID: 7786427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An entirely suprasellar symptomatic Rathke's cleft cyst: case report.
    Itoh J; Usui K
    Neurosurgery; 1992 Apr; 30(4):581-4; discussion 584-5. PubMed ID: 1584358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Craniopharyngioma marsupialization. Case illustration.
    Acakpo-Satchivi L; Tubbs RS; Woolley AL; Bui CJ; Liechty P; Hammers Y; Wellons J; Blount JP; Oakes WJ
    J Neurosurg; 2007 Dec; 107(6 Suppl):521. PubMed ID: 18154027
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.
    Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y
    J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues concerning the treatment of a child with a craniopharyngioma.
    Glod J; Koch B; Myseros J; Breneman J; Collins MH
    Med Pediatr Oncol; 2002 May; 38(5):360-7. PubMed ID: 11979463
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression and inhibition of ADAMDEC1 in craniopharyngioma cells.
    Xu J; Liu L; Zheng X; You C; Li Q
    Neurol Res; 2012 Sep; 34(7):701-6. PubMed ID: 22776555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.